Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-22 Purchase |
2020-09-22 5:14 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
10,000 | $0.7245 | $7,245 | 10,000 (Direct) |
View |
| 2020-09-17 Purchase |
2020-09-17 7:18 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
10,000 | $0.6731 | $6,731 | 10,000 (Direct) |
View |
| 2020-09-14 Purchase |
2020-09-15 6:31 pm |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
10,000 | $0.62 | $6,200 | 11,875 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-01 Option Award |
2020-10-05 6:48 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy |
3,668,984 | $0 | 3,668,984 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:47 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
160,474 | $0.5141 | 450,846 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:47 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
290,372 | $0 | 450,846 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:46 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
151,721 | $0.5141 | 448,073 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:46 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
296,352 | $0 | 448,073 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:45 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
77,805 | $0.5141 | 77,805 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:44 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
396,809 | $0.5141 | 656,106 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:44 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
259,297 | $0 | 656,106 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:43 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
85,586 | $0.5141 | 85,586 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:42 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
116,708 | $0.5141 | 334,310 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:42 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
217,602 | $0 | 334,310 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:41 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
150,748 | $0.5141 | 150,748 (Direct) |
View |